Health
Partnership to Explore Drug Delivery Approaches Labmate Online – Labmate Online
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential…
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential use of its Optimer-based strategies to target renal cells and the feasibility of developing next-generation drug delivery conjugates.
Based on oligonucleotide molecules optimers can bind specifically to a target molecule to act as an antibody alternative. Their ability to fold into distinct secondary or tertiary structures gives them high…
-
Noosa News21 hours agoYoung voices shape Sunshine Coast’s future
-
Business21 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News20 hours agoSXSW Sydney Has Announced the First 40 Speakers That’ll Be Taking to the Stage at Its 2025 Conference